Examination Report |
1 | TM-1 | 25 Jun 2014 |
10 | TM-R(RENEWAL OF TRADE MARK) | 24 Jun 2024 |
2 | Reply to Exam Report (MIS-R) | 17 Mar 2016 |
3 | Reply to Exam Report (MIS-R) | 04 May 2017 |
4 | Reply to Exam Report (MIS-R) | 04 May 2017 |
5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 27 Mar 2018 |
6 | Authorization Document (POA) | 07 May 2018 |
7 | Authorization Document (POA) | 07 May 2018 |
8 | Journal Copy | 18 Jul 2018 |
9 | Certificate | 04 Oct 2018 |
1 | Dispatching of Examination Report for : 2762116 | 2957431 | 1520167 | 29 Jan 2016 |
2 | Abandoned Order for Application No 2762116 | 3417632 | 1785155 | 31 Mar 2016 |
3 | Hearing Notice (Show Cause) | 5928856 | 2672902 | 20 Feb 2018 |
4 | Hearing Notice (Adjourned) | 6194511 | 2792347 | 09 Apr 2018 |
5 | Tribunal Accepted Notice for : 2762116 | 6325615 | 2771906 | 09 May 2018 |
6 | O3 NOTICE | 17972434 | 6730268 | 16 Apr 2024 |
7 | RENEWAL INTIMATION LETTER | 18402788 | 27 Jun 2024 |
The application for Ovalife was made on 25 June 2014.
The trademark applicant for Ovalife is MACLEODS PHARMACEUTICALS.
Ovalife is applied in class(es) 5.
Application for Ovalife is on Registered stage.
Application Id allotted to Ovalife is 2762116.
Trademark agent or attorney for the application is Singh & Singh Law Firm Llp.
Ovalife filed with the Intellectual property office as a DEVICE.